Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of SLC16A1 mRNA | increases expression | 18648102
|
C002202 |
4-oxoretinoic acid |
4-oxoretinoic acid results in decreased expression of SLC16A1 mRNA | decreases expression | 15982314
|
C058176 |
5-nitro-2-(3-phenylpropylamino)benzoic acid |
5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] | decreases reaction|increases uptake | 19023563
|
D000079 |
Acetaldehyde |
Acetaldehyde inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] | decreases reaction|increases uptake | 19023563
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of SLC16A1 mRNA | affects expression | 17562736
|
D000085 |
Acetates |
Acetates inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] | decreases reaction|increases uptake | 19023563
|
C000188 |
alachlor |
alachlor results in increased expression of SLC16A1 mRNA | increases expression | 12419858
|
C103303 |
alitretinoin |
alitretinoin results in decreased expression of SLC16A1 mRNA | decreases expression | 15982314
|
C040534 |
alpha-hexachlorocyclohexane |
alpha-hexachlorocyclohexane affects the expression of SLC16A1 mRNA | affects expression | 16940010
|
C040534 |
alpha-hexachlorocyclohexane |
alpha-hexachlorocyclohexane results in decreased expression of SLC16A1 mRNA | decreases expression | 16940010
|
C040534 |
alpha-hexachlorocyclohexane |
alpha-hexachlorocyclohexane results in increased expression of SLC16A1 mRNA | increases expression | 16940010
|
C005087 |
alpha-ketobutyric acid |
alpha-ketobutyric acid inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] | decreases reaction|increases uptake | 19023563
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SLC16A1 mRNA | affects expression | 16483693
|
D047310 |
Apigenin |
[Apigenin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | decreases activity|decreases uptake | 17108059
|
D001241 |
Aspirin |
Aspirin affects the reaction [SLC16A1 protein results in increased uptake of Butyrates] | affects reaction|increases uptake | 19023563
|
D001241 |
Aspirin |
Aspirin results in decreased expression of SLC16A1 mRNA | decreases expression | 11906190
|
D001554 |
Benzene |
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of SLC16A1 mRNA | affects cotreatment|decreases expression | 17905399
|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of SLC16A1 mRNA | affects cotreatment|decreases expression | 18164116
|
D019817 |
Benzoic Acid |
morin inhibits the reaction [SLC16A1 protein results in increased uptake of Benzoic Acid] | decreases reaction|increases uptake | 17976262
|
D019817 |
Benzoic Acid |
naringenin inhibits the reaction [SLC16A1 protein results in increased uptake of Benzoic Acid] | decreases reaction|increases uptake | 17976262
|
D019817 |
Benzoic Acid |
Quercetin inhibits the reaction [SLC16A1 protein results in increased uptake of Benzoic Acid] | decreases reaction|increases uptake | 17976262
|
D019817 |
Benzoic Acid |
silybin inhibits the reaction [SLC16A1 protein results in increased uptake of Benzoic Acid] | decreases reaction|increases uptake | 17976262
|
D019817 |
Benzoic Acid |
SLC16A1 protein results in increased uptake of Benzoic Acid | increases uptake | 17976262
|
C004541 |
biochanin A |
[biochanin A results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | decreases activity|decreases uptake | 17108059
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of SLC16A1 mRNA | decreases expression | 20678512
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of SLC16A1 mRNA | increases expression | 15901920
|
D002087 |
Butyrates |
5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] | decreases reaction|increases uptake | 19023563
|
D002087 |
Butyrates |
Acetaldehyde inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] | decreases reaction|increases uptake | 19023563
|
D002087 |
Butyrates |
Acetates inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] | decreases reaction|increases uptake | 19023563
|
D002087 |
Butyrates |
alpha-ketobutyric acid inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] | decreases reaction|increases uptake | 19023563
|
D002087 |
Butyrates |
Aspirin affects the reaction [SLC16A1 protein results in increased uptake of Butyrates] | affects reaction|increases uptake | 19023563
|
D002087 |
Butyrates |
Caffeine affects the reaction [SLC16A1 protein results in increased uptake of Butyrates] | affects reaction|increases uptake | 19023563
|
D002087 |
Butyrates |
Indomethacin inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] | decreases reaction|increases uptake | 19023563
|
D002087 |
Butyrates |
Lactic Acid inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] | decreases reaction|increases uptake | 19023563
|
D002087 |
Butyrates |
N-Methyl-3,4-methylenedioxyamphetamine affects the reaction [SLC16A1 protein results in increased uptake of Butyrates] | affects reaction|increases uptake | 19023563
|
D002087 |
Butyrates |
p-Chloromercuribenzoic Acid inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] | decreases reaction|increases uptake | 19023563
|
D002087 |
Butyrates |
Propionates inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] | decreases reaction|increases uptake | 19023563
|
D002087 |
Butyrates |
Pyruvic Acid inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] | decreases reaction|increases uptake | 19023563
|
D002087 |
Butyrates |
SLC16A1 protein results in increased uptake of Butyrates | increases uptake | 19023563
|
D002087 |
Butyrates |
Tetrahydrocannabinol inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] | decreases reaction|increases uptake | 19023563
|
D002087 |
Butyrates |
Theophylline inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] | decreases reaction|increases uptake | 19023563
|
D002087 |
Butyrates |
SLC16A1 protein results in increased transport of Butyrates | increases transport | 16042588 11953883
|
D002110 |
Caffeine |
Caffeine affects the reaction [SLC16A1 protein results in increased uptake of Butyrates] | affects reaction|increases uptake | 19023563
|
D002110 |
Caffeine |
Caffeine results in increased expression of SLC16A1 mRNA | increases expression | 19023563
|
D002713 |
Chlorine |
[Ozone co-treated with Chlorine] results in increased expression of SLC16A1 mRNA | affects cotreatment|increases expression | 18636392
|
D020245 |
p-Chloromercuribenzoic Acid |
p-Chloromercuribenzoic Acid inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] | decreases reaction|increases uptake | 19023563
|
C043561 |
chrysin |
[chrysin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | decreases activity|decreases uptake | 17108059
|
C019304 |
ciprofibrate |
ciprofibrate results in increased expression of SLC16A1 mRNA | increases expression | 12771043
|
D002994 |
Clofibrate |
[Clofibrate results in increased activity of PPARA protein] which results in increased expression of SLC16A1 mRNA | increases activity|increases expression | 18375207
|
D003513 |
Cycloheximide |
[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of SLC16A1 mRNA | affects cotreatment|increases expression | 19684285
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of SLC16A1 mRNA | increases expression | 20106945
|
C014347 |
decitabine |
decitabine affects the methylation of SLC16A1 gene | affects methylation | 17630775
|
C014347 |
decitabine |
[decitabine co-treated with trichostatin A] results in increased expression of SLC16A1 mRNA | affects cotreatment|increases expression | 20678512
|
C014347 |
decitabine |
decitabine results in increased expression of SLC16A1 mRNA | increases expression | 20678512
|
D013759 |
Tetrahydrocannabinol |
Tetrahydrocannabinol inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] | decreases reaction|increases uptake | 19023563
|
D013759 |
Tetrahydrocannabinol |
Tetrahydrocannabinol results in increased expression of SLC16A1 mRNA | increases expression | 19023563
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of SLC16A1 mRNA | increases expression | 18042831
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of SLC16A1 mRNA | increases expression | 12771043
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of SLC16A1 mRNA | affects cotreatment|decreases expression | 18164116
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of SLC16A1 mRNA | increases expression | 19638242
|
C039602 |
diosmetin |
[diosmetin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | decreases activity|decreases uptake | 17108059
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of SLC16A1 mRNA | affects cotreatment|decreases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of SLC16A1 mRNA | increases expression | 19619570
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of SLC16A1 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of SLC16A1 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC16A1 mRNA | affects cotreatment|increases expression | 17942748
|
C017875 |
fisetin |
[fisetin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | decreases activity|decreases uptake | 17108059
|
D005472 |
Fluorouracil |
Fluorouracil results in decreased expression of SLC16A1 mRNA | decreases expression | 16709241
|
D019833 |
Genistein |
[Genistein results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | decreases activity|decreases uptake | 17108059
|
D019833 |
Genistein |
Genistein results in increased expression of SLC16A1 mRNA | increases expression | 15901920
|
C013015 |
hesperetin |
[hesperetin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | decreases activity|decreases uptake | 17108059
|
D012978 |
Sodium Oxybate |
[Apigenin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | decreases activity|decreases uptake | 17108059
|
D012978 |
Sodium Oxybate |
[biochanin A results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | decreases activity|decreases uptake | 17108059
|
D012978 |
Sodium Oxybate |
[chrysin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | decreases activity|decreases uptake | 17108059
|
D012978 |
Sodium Oxybate |
[diosmetin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | decreases activity|decreases uptake | 17108059
|
D012978 |
Sodium Oxybate |
[fisetin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | decreases activity|decreases uptake | 17108059
|
D012978 |
Sodium Oxybate |
[Genistein results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | decreases activity|decreases uptake | 17108059
|
D012978 |
Sodium Oxybate |
[hesperetin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | decreases activity|decreases uptake | 17108059
|
D012978 |
Sodium Oxybate |
[kaempferol results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | decreases activity|decreases uptake | 17108059
|
D012978 |
Sodium Oxybate |
[[Luteolin co-treated with Phloretin] results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | affects cotreatment|decreases activity|decreases uptake | 17108059
|
D012978 |
Sodium Oxybate |
[Luteolin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | decreases activity|decreases uptake | 17108059
|
D012978 |
Sodium Oxybate |
[morin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | decreases activity|decreases uptake | 17108059
|
D012978 |
Sodium Oxybate |
[naringenin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | decreases activity|decreases uptake | 17108059
|
D012978 |
Sodium Oxybate |
[Phloretin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | decreases activity|decreases uptake | 17108059
|
D012978 |
Sodium Oxybate |
[Quercetin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | decreases activity|decreases uptake | 17108059
|
D007213 |
Indomethacin |
Indomethacin inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] | decreases reaction|increases uptake | 19023563
|
D007213 |
Indomethacin |
Indomethacin results in decreased expression of SLC16A1 mRNA | decreases expression | 16984733
|
C006552 |
kaempferol |
[kaempferol results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | decreases activity|decreases uptake | 17108059
|
D007657 |
Ketone Bodies |
Ketone Bodies results in decreased expression of SLC16A1 mRNA | decreases expression | 16807920
|
D007657 |
Ketone Bodies |
Ketone Bodies results in increased expression of SLC16A1 mRNA | increases expression | 15469884
|
D019344 |
Lactic Acid |
Lactic Acid inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] | decreases reaction|increases uptake | 19023563
|
D019344 |
Lactic Acid |
SLC16A1 protein results in increased uptake of Lactic Acid | increases uptake | 11785685
|
D047311 |
Luteolin |
[[Luteolin co-treated with Phloretin] results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | affects cotreatment|decreases activity|decreases uptake | 17108059
|
D047311 |
Luteolin |
[Luteolin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | decreases activity|decreases uptake | 17108059
|
C030957 |
methylmercury II |
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of SLC16A1 mRNA | affects cotreatment|decreases expression | 17905399
|
D018817 |
N-Methyl-3,4-methylenedioxyamphetamine |
N-Methyl-3,4-methylenedioxyamphetamine affects the reaction [SLC16A1 protein results in increased uptake of Butyrates] | affects reaction|increases uptake | 19023563
|
D018817 |
N-Methyl-3,4-methylenedioxyamphetamine |
N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SLC16A1 mRNA | increases expression | 19023563
|
C008548 |
morin |
morin inhibits the reaction [SLC16A1 protein results in increased uptake of Benzoic Acid] | decreases reaction|increases uptake | 17976262
|
C008548 |
morin |
[morin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | decreases activity|decreases uptake | 17108059
|
D009151 |
Mustard Gas |
Mustard Gas affects the expression of SLC16A1 mRNA | affects expression | 15651846
|
C005273 |
naringenin |
naringenin inhibits the reaction [SLC16A1 protein results in increased uptake of Benzoic Acid] | decreases reaction|increases uptake | 17976262
|
C005273 |
naringenin |
[naringenin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | decreases activity|decreases uptake | 17108059
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in increased expression of SLC16A1 mRNA | increases expression | 17616710
|
D010126 |
Ozone |
[Ozone co-treated with Chlorine] results in increased expression of SLC16A1 mRNA | affects cotreatment|increases expression | 18636392
|
C041786 |
palm oil |
palm oil results in increased expression of SLC16A1 mRNA | increases expression | 18042831
|
C076994 |
perfluorooctane sulfonic acid |
perfluorooctane sulfonic acid results in increased expression of SLC16A1 mRNA | increases expression | 17560707
|
D010693 |
Phloretin |
[[Luteolin co-treated with Phloretin] results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | affects cotreatment|decreases activity|decreases uptake | 17108059
|
D010693 |
Phloretin |
[Phloretin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | decreases activity|decreases uptake | 17108059
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC16A1 mRNA | affects binding|increases activity|increases expression | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of SLC16A1 mRNA | increases expression | 18301758 20059764 18445702
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in increased expression of SLC16A1 mRNA] | increases expression|increases reaction | 20059764
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC16A1 mRNA | affects binding|increases activity|increases expression | 18375207
|
D011422 |
Propionates |
Propionates inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] | decreases reaction|increases uptake | 19023563
|
D019289 |
Pyruvic Acid |
Pyruvic Acid inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] | decreases reaction|increases uptake | 19023563
|
D011794 |
Quercetin |
Quercetin inhibits the reaction [SLC16A1 protein results in increased uptake of Benzoic Acid] | decreases reaction|increases uptake | 17976262
|
D011794 |
Quercetin |
[Quercetin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate | decreases activity|decreases uptake | 17108059
|
D015474 |
Isotretinoin |
Isotretinoin results in decreased expression of SLC16A1 mRNA | decreases expression | 15982314
|
C440975 |
silybin |
silybin inhibits the reaction [SLC16A1 protein results in increased uptake of Benzoic Acid] | decreases reaction|increases uptake | 17976262
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of SLC16A1 mRNA | increases expression | 17879257 12760830
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of SLC16A1 mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of SLC16A1 mRNA | affects cotreatment|decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of SLC16A1 mRNA | affects cotreatment|increases expression | 19684285
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of SLC16A1 mRNA | increases expression | 19619570 19684285
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC16A1 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of SLC16A1 mRNA | decreases expression | 16054898
|
D013806 |
Theophylline |
Theophylline inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] | decreases reaction|increases uptake | 19023563
|
C052342 |
topiramate |
topiramate results in increased expression of SLC16A1 mRNA | increases expression | 16979414
|
D014212 |
Tretinoin |
Tretinoin metabolite results in decreased expression of SLC16A1 mRNA | decreases expression | 15982314
|
D014241 |
Trichloroethylene |
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of SLC16A1 mRNA | affects cotreatment|decreases expression | 17905399
|
C012589 |
trichostatin A |
[decitabine co-treated with trichostatin A] results in increased expression of SLC16A1 mRNA | affects cotreatment|increases expression | 20678512
|
C012589 |
trichostatin A |
trichostatin A results in increased expression of SLC16A1 mRNA | increases expression | 20678512
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
3.86 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Isotretinoin |
6.47 | 18769834 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
6.47 | 14514962 15322242 11752688 |
MESH:D000015 |
Abnormalities, Multiple |
|
Isotretinoin |
4.37 | 18769834 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
8.98 | 18287403 |
MESH:D000138 |
Acidosis |
|
Lactic Acid |
8.98 | 20872349 18406487 |
MESH:D017486 |
Acneiform Eruptions |
|
Isotretinoin |
5.59 | 16232082 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
9.70 | 17505938 |
MESH:D000152 |
Acne Vulgaris |
|
Isotretinoin |
9.70 | 16185265 18769834 |
MESH:D055371 |
Acute Lung Injury |
|
Chlorine |
7.07 | 20601635 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
7.07 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
11.06 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
11.06 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
11.06 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
11.06 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Indomethacin |
11.06 | 16537180 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
12.44 | 3712494 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
12.44 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
12.44 | 10737359 6695378 |
MESH:D000236 |
Adenoma |
|
Indomethacin |
12.44 | 11497255 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
13.37 | 19052882 17162532 19061943 18056438 17620307 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
13.37 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
13.37 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.01 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.21 | 16712894 17306315 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
alachlor |
4.00 | 11874814 14769641 |
MESH:D000437 |
Alcoholism |
|
topiramate |
4.49 | 17925516 19331489 18552399 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.06 | 15955085 |
MESH:D016301 |
Alveolar Bone Loss |
|
Indomethacin |
4.68 | 17225004 |
MESH:D000544 |
Alzheimer Disease |
|
Indomethacin |
3.74 | 15579461 17627676 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
3.74 | 15513908 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Tetrahydrocannabinol |
4.38 | 15204022 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
6.71 | 16511603 15504547 17963324 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
6.71 | 11748828 |
MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
3.83 | 17661222 14761424 11369114 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
3.63 | 17084956 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.15 | 10982225 |
MESH:D000855 |
Anorexia |
|
N-Methyl-3,4-methylenedioxyamphetamine |
4.72 | 15146954 |
MESH:D001014 |
Aortic Aneurysm |
|
Indomethacin |
4.20 | 10231640 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Indomethacin |
4.21 | 10388637 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
7.71 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
7.71 | 11256880 |
MESH:D018771 |
Arthralgia |
|
Indomethacin |
4.48 | 2160914 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
5.69 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
5.69 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Indomethacin |
6.18 | 11248219 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
6.18 | 15570426 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
6.18 | 16292516 |
MESH:D001249 |
Asthma |
|
Acetaldehyde |
12.12 | 9600491 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
12.12 | 10378619 |
MESH:D001249 |
Asthma |
|
Ozone |
12.12 | 17854713 16373670 |
MESH:D001249 |
Asthma |
|
Theophylline |
12.12 | 12113382 9701106 |
MESH:D001249 |
Asthma |
|
Tretinoin |
12.12 | 16456186 |
MESH:D055963 |
Asthma, Aspirin-Induced |
|
Aspirin |
4.13 | 20485159 12372130 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
4.30 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Tetrahydrocannabinol |
4.04 | 15815632 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.53 | 18445737 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
3.75 | 19761891 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.75 | 16935849 |
MESH:D001477 |
Bartter Syndrome |
|
Indomethacin |
4.32 | 10684365 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.33 | 1440618 11289319 |
MESH:D001768 |
Blister |
|
Mustard Gas |
4.48 | 19167455 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Clofibrate |
16.97 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
16.97 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
16.97 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
16.97 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.10 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.29 | 15746008 |
MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
4.54 | 16183116 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.25 | 11985600 |
MESH:D001929 |
Brain Edema |
|
Indomethacin |
4.33 | 11481608 |
MESH:D002545 |
Brain Ischemia |
|
Indomethacin |
3.74 | 12524144 |
MESH:D001932 |
Brain Neoplasms |
|
Aspirin |
3.83 | 15481559 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
17.17 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Apigenin |
17.17 | 16541309 17132221 |
MESH:D001943 |
Breast Neoplasms |
|
Aspirin |
17.17 | 15161893 |
MESH:D001943 |
Breast Neoplasms |
|
Benzene |
17.17 | 11921183 17162533 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
17.17 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
17.17 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
17.17 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
17.17 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
17.17 | 19861407 16675129 17261762 17289903 17018787 12948864 18497071 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
17.17 | 19217205 18357371 15136595 16110121 16595493 16557594 18608205 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
17.17 | 16541309 16873071 17200150 |
MESH:D001943 |
Breast Neoplasms |
|
Indomethacin |
17.17 | 17401462 |
MESH:D001943 |
Breast Neoplasms |
|
kaempferol |
17.17 | 16756079 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
17.17 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
17.17 | 20065188 19142967 18629630 17440819 19155303 19221464 19289846 16202921 20135344 19115204 18855134 21152245 19410462 15668708 18821012 19189210 19059307 16873071 19487384 19189212 18425577 19200415 20390343 20544844 20859285 19084267 11161223 17893378 16273361 15565566 18351453 19011961 17049068 18815881 18997820 18984771 20005174 21138602 17242785 19244106 17261762 16818667 19288272 19103187 19066611 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
17.17 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
17.17 | 16873071 16443354 16166294 |
MESH:D001943 |
Breast Neoplasms |
|
Trichloroethylene |
17.17 | 15986119 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.13 | 17626835 15516495 19059883 18315731 16777450 18417511 14754758 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
4.48 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
4.28 | 17687719 10378619 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
3.91 | 16813970 |
MESH:D002056 |
Burns |
|
Indomethacin |
4.04 | 10459503 |
MESH:D002100 |
Cachexia |
|
Indomethacin |
10.14 | 15141370 11239499 15625704 16537180 |
MESH:D002100 |
Cachexia |
|
Ozone |
10.14 | 16183385 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
4.85 | 16962696 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.78 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
3.98 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
6.36 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
6.36 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
3.84 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.47 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
25.11 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
25.11 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
25.11 | 16807293 20007298 18691550 18210153 20101231 16878318 19107877 18506893 19919837 16569478 19208518 19052882 10737359 20727157 16830150 17978847 18494052 17173139 18665156 17138121 19519916 3084413 17055752 19171122 20084675 20214788 19335982 16288022 19394651 21159647 17162532 16935385 18978308 20935162 10672840 16779866 16540662 17761372 20432363 17428255 3581430 18788625 16681979 16328049 16698587 19539802 20512989 19822196 19383236 16502159 18056438 20514400 19418558 18393292 18785209 20524982 18971187 11831363 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
25.11 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
25.11 | 18930000 16332177 16799960 17045692 17088986 17971768 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
25.11 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Indomethacin |
25.11 | 16391822 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
morin |
25.11 | 19539802 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
25.11 | 12508355 19519916 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
25.11 | 17306315 15276417 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
25.11 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
25.11 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.31 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Indomethacin |
4.05 | 11053908 |
MESH:D018276 |
Carcinoma, Medullary |
|
Indomethacin |
4.67 | 14736730 18791128 11352223 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.29 | 17234771 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
8.65 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
8.65 | 18695887 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Indomethacin |
8.65 | 17341418 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
14.70 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
14.70 | 17066447 16757204 18986760 16280240 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Indomethacin |
14.70 | 15482327 12636206 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Isotretinoin |
14.70 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
14.70 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
14.70 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.02 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
5.40 | 19794523 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
5.40 | 18670907 18850075 16120746 |
MESH:D002310 |
Cardiomyopathy, Alcoholic |
|
Acetaldehyde |
5.79 | 10525098 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
6.21 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
kaempferol |
6.21 | 16756079 |
MESH:D002375 |
Catalepsy |
|
Tetrahydrocannabinol |
5.05 | 10318961 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
5.76 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
5.76 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
marker/mechanism |
|
| 11953883 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
19.97 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Clofibrate |
19.97 | 1399818 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
19.97 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
19.97 | 2727394 7505956 17174075 21159647 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
19.97 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
19.97 | 19524636 20056578 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
3.91 | 16129372 |
MESH:D002637 |
Chest Pain |
|
Theophylline |
5.18 | 15238202 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
topiramate |
3.80 | 15650499 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
7.39 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
7.39 | 16835633 |
MESH:D002764 |
Cholecystitis |
|
Indomethacin |
4.48 | 11181007 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
14.93 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
14.93 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
14.93 | 17110522 16105132 15861022 17681005 11677210 16919318 17333356 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
14.93 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.47 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
4.64 | 12621046 16354765 15668235 8697196 15340226 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
4.64 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.05 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
marker/mechanism |
|
| 11953883 |
MESH:D003110 |
Colonic Neoplasms |
|
Aspirin |
14.43 | 12411196 |
MESH:D003110 |
Colonic Neoplasms |
|
Butyrates |
14.43 | 15936596 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
14.43 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
14.43 | 17016597 15001691 17018589 16340194 17725105 17287894 16510598 17172411 17169374 18772588 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
14.43 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
Indomethacin |
14.43 | 15637740 15786552 15936596 11260862 15625704 15963497 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
14.43 | 19056647 15741050 17191121 11134977 19440933 16640504 17148506 |
MESH:D015179 |
Colorectal Neoplasms |
|
Aspirin |
5.44 | 17047198 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
5.44 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
5.44 | 17454858 16524972 17016601 18949393 18802399 18288408 18383874 16391804 15289873 18448328 17255274 16282729 17695437 16331619 20501625 15148649 17401013 17594712 14970324 17094418 16303861 18509181 |
MESH:D015179 |
Colorectal Neoplasms |
|
Indomethacin |
5.44 | 12606626 17054584 18059344 11197048 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
5.44 | 18095365 18852136 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.48 | 14669216 17141729 |
MESH:D018352 |
Coronavirus Infections |
|
Indomethacin |
5.02 | 17302372 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
4.57 | 15643154 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Isotretinoin |
4.57 | 18769834 9879862 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
4.57 | 10048152 15322242 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
4.57 | 17551590 9224671 9125849 9211117 10589399 16925845 14991402 9142499 8800419 9664655 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.11 | 16733453 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.70 | 19031437 |
MESH:D003872 |
Dermatitis |
|
Benzene |
4.10 | 15902427 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
5.21 | 18759878 14531868 12868966 8156756 2524372 8970840 11298694 11906362 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
alachlor |
5.21 | 8428444 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.07 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
2.87 | 3621924 2952479 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
3.17 | 19496084 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
8.41 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
8.41 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
8.41 | 17107852 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
topiramate |
8.41 | 16979414 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
6.91 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
6.91 | 19279558 |
MESH:D003967 |
Diarrhea |
|
Indomethacin |
3.17 | 7907874 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
9.22 | 9022650 6482804 18289764 18648102 8291058 6679447 18692083 16192314 9653073 9328219 7440962 11289319 1440618 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
9.22 | 19370779 11287661 12540782 17906064 10774834 16081117 15619225 12705907 19164858 19739265 14550746 19416960 14986274 10663392 19085960 14725611 12958197 16109766 11834606 18071297 16177239 18713872 12153990 10915739 19420014 16781746 11529661 15968718 19923254 11461765 12594235 16393943 2444490 11739529 16227642 12392966 11743745 16485898 17522070 11421492 17562736 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
9.22 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
9.22 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Trichloroethylene |
9.22 | 7120509 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.41 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.24 | 11462148 |
MESH:D004374 |
Ductus Arteriosus, Patent |
|
Indomethacin |
4.47 | 18446180 16133044 16326151 18043480 17190690 12774134 |
MESH:D004381 |
Duodenal Ulcer |
|
Indomethacin |
3.50 | 11595415 10671773 17151854 11595431 17351913 17329845 11991626 17045617 16699067 11535926 17202747 |
MESH:D050171 |
Dyslipidemias |
|
Clofibrate |
7.11 | 16707586 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
7.11 | 18367378 |
MESH:D004417 |
Dyspnea |
|
Chlorine |
3.94 | 20016425 |
MESH:D004487 |
Edema |
|
Aspirin |
15.29 | 17259670 |
MESH:D004487 |
Edema |
|
Indomethacin |
15.29 | 8985016 10653021 16100529 19703484 7907874 8273558 7990266 |
MESH:D004487 |
Edema |
|
Mustard Gas |
15.29 | 11402378 11428647 11428631 9260866 |
MESH:D004487 |
Edema |
|
pirinixic acid |
15.29 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
15.29 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
9.65 | 18230668 16714409 15322242 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
9.65 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
6.81 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
6.81 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
11.73 | 19294695 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
11.73 | 19294695 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
3.91 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
13.87 | 11473722 19148513 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
13.87 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
13.87 | 19155303 20544844 16202921 17893378 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
13.87 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Indomethacin |
7.09 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
7.09 | 9294722 10568697 |
MESH:D019446 |
Endotoxemia |
|
Indomethacin |
3.83 | 18509659 |
MESH:D004751 |
Enteritis |
|
Indomethacin |
4.06 | 10567023 17763956 16328016 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
Indomethacin |
4.32 | 17980183 |
MESH:D004802 |
Eosinophilia |
|
Indomethacin |
3.40 | 11298111 |
MESH:D004827 |
Epilepsy |
|
Tetrahydrocannabinol |
6.44 | 821787 |
MESH:D004827 |
Epilepsy |
|
topiramate |
6.44 | 19148780 |
MESH:D004832 |
Epilepsy, Absence |
|
Sodium Oxybate |
5.84 | 6254150 |
MESH:D004833 |
Epilepsy, Temporal Lobe |
|
topiramate |
5.58 | 16499746 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
4.48 | 9357497 |
OMIM:245340 |
ERYTHROCYTE LACTATE TRANSPORTER DEFECT |
marker/mechanism |
|
| |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.42 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
8.50 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
8.50 | 16785472 16481741 15173087 16337965 17638652 |
MESH:D004938 |
Esophageal Neoplasms |
|
Indomethacin |
8.50 | 11005569 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
8.50 | 15150132 16805852 15547721 16510608 15623463 15878914 15264214 15547733 16704527 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.08 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.08 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Clofibrate |
27.68 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
27.68 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
27.68 | 18296743 19004024 19551842 17967931 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
27.68 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
27.68 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
27.68 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
27.68 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
2.79 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.80 | 11858732 |
MESH:D005334 |
Fever |
|
Indomethacin |
3.53 | 17627676 11852909 10431976 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.33 | 6705139 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
3.85 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.50 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Indomethacin |
4.22 | 10962813 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
26.00 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
26.00 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Indomethacin |
26.00 | 17994277 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
26.00 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
26.00 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
26.00 | 17994277 |
MESH:D005499 |
Folliculitis |
|
Indomethacin |
4.48 | 11298111 |
MESH:D005739 |
Gas Poisoning |
|
Chlorine |
4.32 | 20016425 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
8.85 | 16983495 |
MESH:D005756 |
Gastritis |
|
Indomethacin |
8.85 | 15046732 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.00 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.54 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Aspirin |
30.96 | 12870263 |
MESH:D005909 |
Glioblastoma |
|
biochanin A |
30.96 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
30.96 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Indomethacin |
30.96 | 12870263 |
MESH:D005909 |
Glioblastoma |
|
perfluorooctane sulfonic acid |
30.96 | 17162496 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
30.96 | 19804834 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
30.96 | 17312396 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
30.96 | 18801729 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
8.10 | 16145905 |
MESH:D005910 |
Glioma |
|
Indomethacin |
8.10 | 18371953 16487511 |
MESH:D005910 |
Glioma |
|
Quercetin |
8.10 | 17643826 |
MESH:D005923 |
Glomerulosclerosis, Focal Segmental |
|
Indomethacin |
3.73 | 11849393 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.41 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.90 | 10696789 |
MESH:D006073 |
Gout |
|
Indomethacin |
4.67 | 11248219 |
MESH:D006261 |
Headache |
|
Aspirin |
4.27 | 15240983 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
14.47 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
14.47 | 15162350 15102660 18337622 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Indomethacin |
14.47 | 15482327 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
14.47 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.47 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.19 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
5.19 | 14991402 9664655 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.09 | 20558911 |
MESH:D006402 |
Hematologic Diseases |
|
Benzene |
4.02 | 16183116 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.74 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.72 | 11000095 |
MESH:D006501 |
Hepatic Encephalopathy |
|
Indomethacin |
3.96 | 15633222 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
7.60 | 6705139 |
MESH:D006505 |
Hepatitis |
|
Caffeine |
7.60 | 11394713 |
MESH:D019698 |
Hepatitis C, Chronic |
|
Indomethacin |
4.04 | 15135802 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
6.08 | 16221962 19176532 18467677 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
6.08 | 15340226 12621046 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.34 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.60 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.07 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.35 | 16959395 15340226 16354765 18606429 8697196 |
MESH:D012001 |
Hyperacusis |
|
Aspirin |
5.07 | 15240983 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
9.90 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Indomethacin |
9.90 | 12727271 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
9.90 | 16870215 |
MESH:D034321 |
Hyperamylasemia |
|
Indomethacin |
5.02 | 17883296 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
2.99 | 21332399 |
MESH:D006940 |
Hyperemia |
|
Indomethacin |
4.33 | 12524144 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
3.90 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
kaempferol |
12.36 | 18262572 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
12.36 | 20558911 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
12.36 | 11834736 18262572 |
MESH:C538376 |
Hyperinsulinemic hypoglycemia, familial, 7 |
marker/mechanism |
|
| |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
7.26 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Indomethacin |
7.26 | 17546600 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.28 | 15034207 |
MESH:D006973 |
Hypertension |
|
Benzene |
9.78 | 17940673 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
9.78 | 10903974 |
MESH:D006973 |
Hypertension |
|
Quercetin |
9.78 | 18356687 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
9.78 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.15 | 16569931 16945680 |
MESH:D007035 |
Hypothermia |
|
Tetrahydrocannabinol |
5.27 | 10318961 |
MESH:D007077 |
Ileal Diseases |
|
Indomethacin |
4.33 | 18306037 10574470 |
MESH:D007079 |
Ileitis |
|
Indomethacin |
4.67 | 10651667 10647630 16133968 |
MESH:D007235 |
Infant, Premature, Diseases |
|
Indomethacin |
4.68 | 16133044 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
2.83 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
alachlor |
16.05 | 16466525 17049205 12948887 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
16.05 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
16.05 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
16.05 | 15346721 12646999 |
MESH:D007248 |
Infertility, Male |
|
Theophylline |
16.05 | 16988215 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
14.77 | 20412841 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
14.77 | 18785209 |
MESH:D007249 |
Inflammation |
|
Indomethacin |
14.77 | 7812673 3291741 12568917 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
14.77 | 16001271 9357497 11402378 17524151 11428631 11428620 9260866 8975870 11428647 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
14.77 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
14.77 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
3.82 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
13.73 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
13.73 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
13.73 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
13.73 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Indomethacin |
7.69 | 15610444 18236018 17329856 11686837 11713966 17994277 10210152 11855677 15831440 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
7.69 | 17994277 |
MESH:D019586 |
Intracranial Hypertension |
|
Indomethacin |
4.68 | 15241188 |
MESH:D007511 |
Ischemia |
|
morin |
5.26 | 16806951 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.33 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
7.90 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
7.90 | 15992940 17551590 |
MESH:D007579 |
Jejunal Diseases |
|
Indomethacin |
4.33 | 16133968 18306037 10574470 |
MESH:D007627 |
Keloid |
|
Quercetin |
4.29 | 17086741 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.75 | 15604871 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
4.96 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
18.27 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
18.27 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
18.27 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Indomethacin |
18.27 | 17190690 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
18.27 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
18.27 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
17.41 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
17.41 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
17.41 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
17.41 | 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
17.41 | 18625569 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Indomethacin |
3.35 | 12228301 10320625 11703811 |
MESH:D007938 |
Leukemia |
|
alachlor |
23.82 | 14769641 |
MESH:D007938 |
Leukemia |
|
Benzene |
23.82 | 15935818 18335105 17119257 14694614 |
MESH:D007938 |
Leukemia |
|
decitabine |
23.82 | 19235587 18980019 |
MESH:D007938 |
Leukemia |
|
Genistein |
23.82 | 17468513 18980019 |
MESH:D007938 |
Leukemia |
|
kaempferol |
23.82 | 17468513 |
MESH:D007938 |
Leukemia |
|
Quercetin |
23.82 | 17468513 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
23.82 | 17143497 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Indomethacin |
3.40 | 16572323 15631656 10785260 |
MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
12.54 | 17506065 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
12.54 | 18454857 19117987 17236224 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
12.54 | 16932348 16482212 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
9.77 | 19478238 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
9.77 | 18206229 17679729 19010910 18704418 19387464 18460780 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Indomethacin |
9.77 | 18360721 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
9.77 | 17596541 16294345 19850784 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
9.77 | 18206229 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
4.77 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
2.68 | 17339181 17368321 17361223 19225113 17649720 16331271 16935935 9834237 17301526 17217047 17294898 16140955 19075265 12679006 16823087 19035177 16891316 15748426 17107899 19642359 16788101 19029980 17506722 16766008 17712046 |
MESH:D007964 |
Leukocytosis |
|
Indomethacin |
4.68 | 16537180 |
MESH:D007969 |
Leukomalacia, Periventricular |
|
Indomethacin |
5.02 | 17980183 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
2.80 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.65 | 17567588 15342952 |
MESH:D008101 |
Liver Abscess, Amebic |
|
Indomethacin |
5.02 | 11479899 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
5.24 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
5.24 | 18665156 20032147 18407596 18522880 19638242 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
2.74 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
17.75 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
17.75 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Indomethacin |
17.75 | 18194892 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
morin |
17.75 | 18629640 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
naringenin |
17.75 | 14709902 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
17.75 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
17.75 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
silybin |
17.75 | 16169303 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
17.75 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
17.75 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
17.75 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
5.36 | 16610002 16611625 19014921 12969438 19784758 12587719 19460945 11587558 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
5.36 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
naringenin |
5.36 | 16945181 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
2.64 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
23.82 | 19389873 21295105 |
MESH:D008113 |
Liver Neoplasms |
|
ciprofibrate |
23.82 | 12771043 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
23.82 | 19427195 15885732 21278145 19254457 16942905 20434301 19256749 21047994 18754104 2862719 12771043 2422723 12112319 18978307 20137499 19996281 19638242 20405173 19294768 21071580 18644402 19850985 19690152 21167192 19499222 10737359 19426721 19255062 19812893 20101389 19833225 20118626 20452335 19642983 18977376 19090486 9163691 15175105 19073162 20492335 19551842 20501860 18648771 20583210 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
23.82 | 15113037 16603448 17045692 18383874 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
23.82 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
23.82 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
23.82 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
23.82 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
23.82 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
25.23 | 3712494 598648 1399818 6587162 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
25.23 | 12562636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
25.23 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
25.23 | 3124819 19009564 21159647 18775883 18282651 19539802 16842330 18253720 17174075 18164116 17854601 16267830 9362446 18544905 2563599 19126423 19519916 18079962 19004024 18093689 17942915 18308698 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
morin |
25.23 | 19539802 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
25.23 | 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
25.23 | 12151625 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Trichloroethylene |
25.23 | 7955063 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
9.59 | 18161513 18702808 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
9.59 | 8266340 19066396 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
9.59 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
4.12 | 14698565 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.20 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Acetaldehyde |
24.97 | 17372256 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
24.97 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
Benzene |
24.97 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
24.97 | 6695378 21163286 20512841 20970405 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
24.97 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Indomethacin |
24.97 | 11497255 11053908 16537180 |
MESH:D008175 |
Lung Neoplasms |
|
Isotretinoin |
24.97 | 15899809 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
24.97 | 3148597 8781369 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
24.97 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
24.97 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
silybin |
24.97 | 16788158 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
24.97 | 15276417 17077188 17306315 16712894 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
24.97 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
24.97 | 11884234 19555203 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.11 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Benzene |
6.14 | 17119257 17584886 |
MESH:D008223 |
Lymphoma |
|
decitabine |
6.14 | 19470736 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
7.83 | 12562636 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
7.83 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
10.46 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
10.46 | 11408345 16891317 17203775 11807958 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
10.46 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
10.46 | 16827153 11731420 19196723 14580682 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
10.35 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
10.35 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.47 | 17453147 |
MESH:D008545 |
Melanoma |
|
decitabine |
10.23 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
Isotretinoin |
10.23 | 17237267 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
10.23 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
10.23 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
10.23 | 16752155 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
10.23 | 16505122 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.50 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
2.91 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.76 | 16940565 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.09 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.41 | 10496685 |
MESH:D008881 |
Migraine Disorders |
|
Aspirin |
9.96 | 15240983 |
MESH:D008881 |
Migraine Disorders |
|
Indomethacin |
9.96 | 11903285 |
MESH:D008881 |
Migraine Disorders |
|
topiramate |
9.96 | 18803445 18765137 18759728 16942474 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
7.04 | 16757204 18986760 |
MESH:D009062 |
Mouth Neoplasms |
|
Indomethacin |
7.04 | 12636206 |
MESH:D009101 |
Multiple Myeloma |
|
alachlor |
13.22 | 14769641 |
MESH:D009101 |
Multiple Myeloma |
|
Benzene |
13.22 | 17119195 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
13.22 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
13.22 | 18172295 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
2.85 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
6.04 | 19010910 18608210 19157545 16882708 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
6.04 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Aspirin |
10.80 | 12692751 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
10.80 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
10.80 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
10.80 | 19595682 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.47 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
15.89 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
15.89 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
15.89 | 16411023 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
15.89 | 19207477 |
MESH:D009325 |
Nausea |
|
Aspirin |
4.52 | 15240983 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
10.88 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
10.88 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
Indomethacin |
10.88 | 11053908 11239499 16537180 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
10.88 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.25 | 19410462 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
25.24 | 16946489 |
MESH:D009369 |
Neoplasms |
|
decitabine |
25.24 | 17925555 19116145 19470736 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
25.24 | 18239605 18600527 16928823 |
MESH:D009369 |
Neoplasms |
|
naringenin |
25.24 | 15185748 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
25.24 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
25.24 | 15185748 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
25.24 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
25.24 | 16946489 16594593 |
MESH:D009369 |
Neoplasms |
|
Trichloroethylene |
25.24 | 11911487 |
MESH:D009374 |
Neoplasms, Experimental |
|
Indomethacin |
7.09 | 10663608 15625704 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
7.09 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.31 | 19196722 19200415 19189210 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.06 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.75 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
2.70 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
23.94 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
23.94 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
23.94 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
23.94 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
23.94 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
17.77 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Benzene |
17.77 | 15643154 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
17.77 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tetrahydrocannabinol |
17.77 | 19040278 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
17.77 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Isotretinoin |
3.65 | 17368321 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
10.81 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
10.81 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Indomethacin |
10.81 | 12349958 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
3.73 | 17929310 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.42 | 20387270 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
2.95 | 16436463 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
3.35 | 16761898 7688884 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
Clofibrate |
4.27 | 9802331 |
MESH:D009669 |
Nose Neoplasms |
|
alachlor |
4.15 | 14563481 15580706 16698726 11127290 16178123 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
3.69 | 16723640 18674790 20518802 21332399 11836018 19632207 18457598 17217161 20132043 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
3.69 | 20558911 |
MESH:D007752 |
Obstetric Labor, Premature |
|
Indomethacin |
4.48 | 6374098 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
7.18 | 4026338 6482804 |
MESH:D009784 |
Occupational Diseases |
|
Benzene |
7.18 | 15612468 15576619 15935809 17119257 17479406 15727169 15913788 17178637 16737584 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.33 | 3988306 |
MESH:D010003 |
Osteoarthritis |
|
Aspirin |
6.52 | 7009135 |
MESH:D010003 |
Osteoarthritis |
|
Indomethacin |
6.52 | 7009135 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
6.17 | 19401787 |
MESH:D010024 |
Osteoporosis |
|
kaempferol |
6.17 | 16756079 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
8.05 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
8.05 | 19495926 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.31 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
26.02 | 12562636 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
26.02 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
26.02 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
26.02 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Luteolin |
26.02 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
26.02 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
26.02 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
26.02 | 16936753 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
26.02 | 19331143 |
MESH:D010146 |
Pain |
|
Acetaminophen |
11.59 | 16870215 |
MESH:D010146 |
Pain |
|
Aspirin |
11.59 | 6363464 6995502 |
MESH:D010146 |
Pain |
|
Indomethacin |
11.59 | 17627676 3291741 17440234 13679232 |
MESH:D010146 |
Pain |
|
Tretinoin |
11.59 | 16870215 |
MESH:D010149 |
Pain, Postoperative |
|
Indomethacin |
3.99 | 18702446 12538197 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
16.56 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
16.56 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
16.56 | 16929163 19003803 15113037 16500647 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
16.56 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
16.56 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
16.56 | 19294695 |
MESH:D010195 |
Pancreatitis |
|
Indomethacin |
3.31 | 15028970 17883296 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.06 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
2.83 | 7296757 |
MESH:D010257 |
Paraneoplastic Syndromes |
|
Indomethacin |
5.02 | 16537180 |
MESH:D020734 |
Parkinsonian Disorders |
|
Indomethacin |
3.53 | 12349958 |
MESH:D051302 |
Paroxysmal Hemicrania |
|
Indomethacin |
5.02 | 11903285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.56 | 12520081 |
MESH:D010437 |
Peptic Ulcer |
|
Indomethacin |
4.47 | 11148446 |
MESH:D010438 |
Peptic Ulcer Hemorrhage |
|
Aspirin |
4.86 | 11156591 |
MESH:D010518 |
Periodontitis |
|
Indomethacin |
4.22 | 17225004 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.47 | 16369182 |
MESH:D020795 |
Photophobia |
|
Aspirin |
5.07 | 15240983 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
3.78 | 6228378 |
MESH:D011014 |
Pneumonia |
|
Ozone |
3.72 | 18929643 18381685 18007984 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
3.18 | 15727166 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
5.31 | 16144296 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
2.91 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
11.97 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
11.97 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
11.97 | 19056647 |
MESH:D047928 |
Premature Birth |
|
Indomethacin |
4.46 | 17000239 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
12.49 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Isotretinoin |
12.49 | 18769834 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
12.49 | 11896295 11222880 11118676 11399792 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
10.22 | 17616702 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
10.22 | 17616702 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
8.51 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
8.51 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Apigenin |
3.66 | 17132221 |
MESH:D011471 |
Prostatic Neoplasms |
|
biochanin A |
3.66 | 12111696 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.66 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.66 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
fisetin |
3.66 | 18922931 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
3.66 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
3.66 | 16925846 15378649 15256057 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
3.66 | 14715546 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.66 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.66 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
3.66 | 19789329 18798265 |
MESH:D011507 |
Proteinuria |
|
Indomethacin |
7.26 | 11849393 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
7.26 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
7.29 | 15861022 16919318 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
7.29 | 18058305 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
1.95 | 16882103 |
MESH:D011596 |
Psychomotor Disorders |
|
Isotretinoin |
5.24 | 18769834 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.11 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.11 | 10548101 |
MESH:D029424 |
Pulmonary Disease, Chronic Obstructive |
|
Theophylline |
4.60 | 18983928 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
2.63 | 17894541 10334151 17266442 17620002 17720292 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.43 | 18286688 18722050 16160472 15538739 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.01 | 19058328 |
MESH:D012120 |
Respiration Disorders |
|
Chlorine |
4.52 | 18579056 |
MESH:D012135 |
Respiratory Sounds |
|
alachlor |
4.29 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.19 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
2.85 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
8.85 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
8.85 | 16283617 16116481 |
MESH:D012220 |
Rhinitis |
|
Acetaldehyde |
7.39 | 17050345 |
MESH:D012220 |
Rhinitis |
|
Aspirin |
7.39 | 12372130 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
4.85 | 16862918 |
MESH:D012640 |
Seizures |
|
topiramate |
3.67 | 16499746 |
MESH:D012851 |
Sinus Thrombosis, Intracranial |
|
Aspirin |
4.60 | 12269725 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
2.50 | 16961503 12880345 15451306 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
7.27 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
7.27 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
7.27 | 16467112 |
MESH:D012893 |
Sleep Disorders |
|
Caffeine |
4.64 | 19395429 |
MESH:D007319 |
Sleep Initiation and Maintenance Disorders |
|
Caffeine |
4.42 | 17225163 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
9.26 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
9.26 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.36 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.26 | 12854658 |
MESH:D013272 |
Stomach Diseases |
|
Indomethacin |
3.74 | 16280098 17160473 17638125 15038085 15472012 18209964 16113693 10215738 16184426 10486359 17207306 10192188 18545984 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
8.74 | 12562636 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
8.74 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
8.74 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
8.74 | 17172411 16424979 18567086 19084572 18396642 15786421 19015929 17498489 16951190 17522103 |
MESH:D013274 |
Stomach Neoplasms |
|
Indomethacin |
8.74 | 15609394 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
8.74 | 12958204 17575124 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
8.74 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Indomethacin |
3.00 | 11523592 17627676 16169175 16150113 18237397 16755016 16934674 12498302 18193104 16252198 11906479 12077510 18726076 18543354 17654042 18087811 12787963 15138204 18181030 17918041 15255614 12500499 18209962 10423059 1323529 12467913 17657623 10878458 11595431 11595415 17977527 11145282 16631530 15104355 18299717 11729361 17135157 14567935 10750652 16397915 18431645 17895592 |
MESH:D020521 |
Stroke |
|
Aspirin |
3.83 | 16403987 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.31 | 16684133 16045194 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
2.99 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Aspirin |
7.27 | 17672075 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
7.27 | 15669648 |
MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
4.28 | 10850423 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.21 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
25.66 | 1399818 6587162 3712494 7505956 6582329 |
MESH:D013964 |
Thyroid Neoplasms |
|
alachlor |
25.66 | 8812207 |
MESH:D013964 |
Thyroid Neoplasms |
|
Butyrates |
25.66 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
25.66 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
25.66 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Indomethacin |
25.66 | 14736730 11352223 18791128 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
25.66 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
3.99 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
7.85 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
7.85 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.77 | 16040207 |
MESH:D014456 |
Ulcer |
|
Indomethacin |
4.22 | 17380554 10574470 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
12.36 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
12.36 | 17616700 19087683 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
12.36 | 16720314 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
12.36 | 11723127 16452187 17306315 16712894 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
12.36 | 17572228 8653321 16712894 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
6.83 | 10982225 |
MESH:D014581 |
Urticaria |
|
Aspirin |
6.83 | 10982225 20485159 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
12.42 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
12.42 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
12.42 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.32 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
7.43 | 12562636 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
7.43 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
10.53 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
10.53 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.29 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
3.75 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.90 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
2.93 | 15869587 14671159 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.41 | 16761959 |
MESH:D014839 |
Vomiting |
|
Indomethacin |
4.06 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.56 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.16 | 16723640 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.38 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.75 | 17120751 |